QAU Faculty | Pharmacy | Dr. Amjad Khan

Infectious diseases; Nephrology; Clinical Pharmacy Education and Epidemiology; Clinical Trials

1.     Habiba, UE., Khan, A., Mmbaga, EJ., Green, IR., Asaduzzaman, M. (2023). Use of antibiotics in poultry and poultry farmers- A cross-sectional survey in Pakistan. Frontiers in Public Health, 11, 1154668. https://doi.org/10.3389/fpubh.2023.1154668

2.     Hayat, M., Ahmad, N., Khan, S. L. A., Mohkumuddin, S., Siddique, W., Khan, A., & Atif, M. (2023). Pattern, frequency and factors associated with inappropriate high dosing in chronic kidney disease patients at a tertiary care hospital in Pakistan. BMC Nephrology, 24(1), 118. https://doi.org/10.1186/s12882-023-03167-5

3.     Hameed, K., Chinnam, S., Khan, KS., Mushtaq, S.,……..& Khan, A*. (2023). Evaluation of hypertension control among hemodialysis patients in Pakistan: a prospective follow-up study. Blood Pressure Monitoring, 10-1097. http://doi.org/10.1097/MBP.0000000000000656

4.     Hayat, M., Ahmad, N.*, Mohkumuddin, S., Khan, S.L.A., Khan, A.H, Haq, N.U., Haque, N., Khan, A. (2023). Frequency, types and predictors of drug therapy problems among non-dialysis chronic kidney disease patients at a tertiary care hospital in Pakistan. PLoS ONE 18(4), e0284439. https://doi.org/10.1371/journal.pone.0284439

5.     Bibi, A., Abbas, S., Mushtaq, S., Mansoor, A., Green, I. R., Mallhi, T. H., ... & Khan, A*. (2023). Knowledge, Attitudes and Perceptions towards COVID-19 Vaccinations: A Cross-Sectional Survey in Pakistan. Medicina, 59(2), 272. https://doi.org/10.3390/medicina59020272

6.     Bibi, S., Khan, A.*, Khan, A. H., Khan, M. N., Mushtaq, S., & Rashid, S. A. (2022). Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second-and third-generation drug-eluting stents. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.900798

7.     Saleem, S. S., Khan, A.*, Aman, R., Saleem, S. S., Bibi, A., Ahmad, N., ... & Shah, K. U. (2022). Impact of pharmacist-led educational intervention on knowledge of self-management among asthmatic patients: a prospective cohort study. BMJ open, 12(6), e058861. http://dx.doi.org/10.1136/bmjopen-2021-058861

8.     Khan, Y. H., Mallhi, T. H., Alanazi, A. S., Butt, M. H., Khan, A., & Salman, M. (2022). Outbreak of Acute Hepatitis of Unknown etiology in Children; The Critical Role of Healthcare Professionals in Neutralizing Misleading Narratives during the COVID-19 Pandemic. Journal of Medical Virology, 94, 4063-4. https://doi.org/10.1002/jmv.27819

9.     Mushtaq, S., Hashmi, A. H., Khan, A., Asad Raza Kazmi, S. M., & Manzoor, S. (2022). Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals. Frontiers in pharmacology, 1289. https://doi.org/10.3389/fphar.2022.894460

10. Khan, F. U., Khan, A., Khan, F. U., Hayat, K., Chang, J., Khalid, W., ... & Fang, Y. (2022). Assessment of adverse drug events, their risk factors, and management among patients treated for multidrug-resistant TB: A prospective cohort study from Pakistan. Frontiers in Pharmacology, 1270. https://doi.org/10.3389/fphar.2022.876955

11. Khan, A.*, Bibi, S., Kanwal, H., & Hussain, H. (2022). Omicron: a new face of COVID‐19 pandemic. Health Science Reports, 5(2). https://doi.org/10.1002/hsr2.526

12. Khan, F. U., Rehman, A. U., Khan, F. U., Hayat, K., Khan, A., Ahmad, N., ... & Fang, Y. (2022). Assessment of Factors Associated with Unfavorable Outcomes among Drug-Resistant TB Patients: A 6-Year Retrospective Study from Pakistan. International Journal of Environmental Research and Public Health, 19(3), 1574. https://doi.org/10.3390/ijerph19031574

13. Mohamed, K., Rzymski, P., Islam, M. S., Makuku, R., Mushtaq, A., Khan, A., ... & Rezaei, N. (2022). COVID‐19 vaccinations: The unknowns, challenges, and hopes. Journal of medical virology, 94(4), 1336-1349. https://doi.org/10.1002/jmv.27487

14. Naz, F., Ahmad, N., Wahid, A., Ahmad, I., Khan, A., Abubakar, M., ... & Ghafoor, A. (2021). High rate of successful treatment outcomes among childhood rifampicin/multidrug-resistant tuberculosis in Pakistan: a multicentre retrospective observational analysis. BMC infectious diseases, 21(1), 1-11. https://doi.org/10.1186/s12879-021-06935-6

15. Khan, F. U., Khan, A., Shah, S., Hayat, K., Usman, A., Khan, F. U., ... & Fang, Y. (2021). Exploring Undergraduate Pharmacy Students Perspectives Towards Antibiotics Use, Antibiotic Resistance, and Antibiotic Stewardship Programs Along With the Pharmacy Teachers’ Perspectives: A Mixed-Methods Study From Pakistan. Frontiers in pharmacology, 12. https://doi.org/10.3389/fphar.2021.754000

16. Akbar, Z., Rehman, S., Khan, A., Khan, A., Atif, M., & Ahmad, N. (2021). Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study. Journal of Pharmaceutical Policy and Practice, 14(1), 1-9. https://link.springer.com/article/10.1186/s40545-021-00348-1

17. Hussain, H., Ali, I., Wang, D., Hakkim, F. L., Westermann, B., Ahmed, I., Ashour, M.A., Khan, A., ... & Shah, S. T. A. (2021). Glycyrrhetinic acid: A promising scaffold for the discovery of anticancer agents. Expert Opinion on Drug Discovery, 16(12), 1497-1516. https://doi.org/10.1080/17460441.2021.1956901

18. Bibi, S., Khan, A.*, Nadeem, A., Mushtaq, S., & Khan, G. M. (2021). Assessment of utility values and QALYs after primary PCI with DP-Xience and BP-Biomatrix stents. Plos one, 16(6), e0253290. https://doi.org/10.1371/journal.pone.0253290

19. Abubakar, M., Ahmad, N., Ghafoor, A., Latif, A., Ahmad, I., Atif, M., Saleem F., Khan, S., Khan, A., ... & Khan, A. H. (2021). Treatment outcomes of extensively drug-resistant tuberculosis in Pakistan: a countrywide retrospective record review. Frontiers in pharmacology, 12, 640555. https://doi.org/10.3389/fphar.2021.640555

20. Ahmed, A., Saqlain, M., Bashir, N., Dujaili, J., Hashmi, F., Mazhar, F., Khan, A., ... & Awaisu, A. (2021). Health-related quality of life and its predictors among adults living with HIV/AIDS and receiving antiretroviral therapy in Pakistan. Quality of Life Research, 30(6), 1653-1664. https://doi.org/10.1007/s11136-021-02771-y

21. Khan, F. U., Khan, F. U., Hayat, K., Ahmad, T., Khan, A., Chang, J., ... & Fang, Y. (2021). Knowledge, attitude, and practice on antibiotics and its resistance: A two-phase mixed-methods online study among Pakistani community pharmacists to promote rational antibiotic use. International journal of environmental research and public health, 18(3), 1320. https://doi.org/10.3390/ijerph18031320

22. Khan, A.*, Bibi, A., Sheraz Khan, K., Raza Butt, A., Alvi, H. A., Zahra Naqvi, A., ... & Ahmad, N. (2020). Routine pediatric vaccination in Pakistan during COVID-19: how can healthcare professionals help?. Frontiers in Pediatrics, 8, 859. https://doi.org/10.3389/fped.2020.613433

23. Chatha, Z. F., Rashid, U., Olsen, S., Khan, A.*, Nawaz, K., Gan, S. H., & Khan, G. M. (2020). Pharmacist-led counselling intervention to improve antiretroviral drug adherence in Pakistan: a randomized controlled trial. BMC infectious diseases, 20(1), 1-10. https://doi.org/10.1186/s12879-020-05571-w

24. Mushtaq, S., Akhter, T. S., Khan, A., Sohail, A., Khan, A.*, & Manzoor, S. (2020). Efficacy and safety of generic sofosbuvir plus daclatasvir and sofosbuvir/velpatasvir in HCV genotype 3-infected patients: real-world outcomes from Pakistan. Frontiers in Pharmacology, 11, 550205. https://doi.org/10.3389/fphar.2020.550205

25. Mallhi, T. H., Khan, Y. H., Alotaibi, N. H., Alzarea, A. I., Tanveer, N., & Khan, A. (2020). Celebrating Eid-ul-Adha in the era of the COVID-19 pandemic in Pakistan: potential threats and precautionary measures. Clinical Microbiology and Infection, 26(12), 1714-1715. https://doi.org/10.1016/j.cmi.2020.07.019

26. Ahmad, N., Wahid, A., Khan, A., Atif, M., & Khan, A. (2020). Evaluation of management and factors associated with hypertension control in hemodialysis patients at a tertiary-care hospital in Pakistan. Drugs & Therapy Perspectives, 36(9), 396-403. https://doi.org/10.1007/s40267-020-00763-5

27. Mushtaq, S., Mansoor, A., Umar, M., Khan, A., Siddiqi, S., & Manzoor, S. (2020). Direct‐acting antiviral agents in the treatment of chronic hepatitis C—Real‐life experience from clinical practices in Pakistan. Journal of Medical Virology, 92(12), 3475-3487. https://doi.org/10.1002/jmv.25745



28. Mallhi, T. H., Khan, Y. H., Khan, A., Alotaibi, N. H., Alzarea, A. I., & Hashmi, F. K. (2019). The association of HIV and easy access to narcotics in Pakistan; calling drug policy makers. Journal of pharmaceutical policy and practice, 12(1), 1-4. https://doi.org/10.1186/s40545-019-0199-5

29. Rehman, N. U., Hussain, H., Ali, L., Khan, A., Mabood, F., Shinwari, Z. K., ... & Al-Harrasi, A. (2019). Chemical constituents of acridocarpus orientalis and their chemotaxonomic significance. Chemistry of Natural Compounds, 55(3), 586-588. https://doi.org/10.1007/s10600-019-02752-1

30. Khan, A.*, Khan, A. H., Adnan, A. S., Sulaiman, S. A. S., & Mushtaq, S. (2019). Prevalence and predictors of depression among hemodialysis patients: a prospective follow-up study. BMC public health, 19(1), 1-13. https://doi.org/10.1186/s12889-019-6796-z

31. Khan, A.*, Khan, A. H., Adnan, A. S., Sulaiman, S. A. S., Mushtaq, S., Ahmad, N., & Khan, I. (2019). Hypertension control among euvolemic hypertensive hemodialysis patients in Malaysia: a prospective follow-up study. Journal of pharmaceutical policy and practice, 12(1), 1-13. https://doi.org/10.1186/s40545-019-0169-y

32. Khan, A.*, Khan, A. H., Adnan, A. S., Sulaiman, S. A. S., Ahmad, N., & Gan, S. H. (2019). Evaluation of factors affecting time to achieve dry weight among hemodialysis patients using bioimpedance spectroscopy. Irish Journal of Medical Science (1971-), 188(1), 311-319. https://doi.org/10.1007/s11845-018-1813-2

33. Ahmad, N., Khan, A. H., Khan, I., Khan, A., & Atif, M. (2018). Doctors’ knowledge of hypertension guidelines recommendations reflected in their practice. International journal of hypertension, 2018. https://doi.org/10.1155/2018/8524063

34. Khan, I., Khan, A. H., Adnan, A. S., Sulaiman, S. A. S., Hamzah, A. B. A., Ahmed, N., & Khan, A. (2018). Effect of socio-demographic factors on endogenous biomarkers (cystatin C and creatinine) among elderly chronic kidney disease patients: a cross-sectional study. International urology and nephrology, 50(6), 1113-1121. https://doi.org/10.1007/s11255-018-1834-9

35. Bitar, A. N., Khan, A. H., Khan, A. (2018). Clinical assessment, evaluation, and categorization of medication errors. International journal of biology, pharmacy and allied sciences, 7(12), 2104-2119. https://doi.org/10.31032/IJBPAS/2018/7.12.4601

36. Wahab, A., Khan, G. M., Sharifi, M., Khan, A., Khan, A., & Khan, N. (2018). Preparation, solid state characterization and evaluation of ketoprofen-glucosamine HCl solid dispersions. Archieves of pharmacy and pharmaceutical sciences, 2: 010-019. https://www.heighpubs.org/hps/apps-aid1007.php

37. Rehman, F. U., Shah, K. U., Shah, S. U., Khan, I. U., Khan, G. M., & Khan, A. (2017). From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS). Expert opinion on drug delivery, 14(11), 1325-1340. https://doi.org/10.1080/17425247.2016.1218462

38. Khan, A.*, Khan, A., Wazir, N. N., Ullah, N., & Khan, O. H. (2017). Relapse multifocal osteomyelitis secondary to septicemia: A case study. Archives of Pharmacy Practice, 8(1), 31-34. https://archivepp.com/article/relapse-multifocal-osteomyelitis-secondary-to-septicemia-a-case-study

39. Daar, J., Khan, A., Khan, J., Khan, A., & Khan, G. M. (2017). Studies on self-nanoemulsifying drug delivery system of flurbiprofen employing long, medium and short chain triglycerides. Pak. J. Pharm. Sci, 30(2), 601-606.

40. Khan, A., Khan, J., Irfan, M., Naqvi, S. B. S., Khan, G. M., Shoaib, M. H., ... & Khan, A. (2017). Validation and application of high performance liquid chromatographic method for the estimation of metoclopramide hydrochloride in plasma. Pak J Pham Sci, 30(1), 143-147.

41. Khan, A.*, Khan, A. H., Adnan, A. S., Sulaiman, S. A., & Khan, I. (2017). Dry-Weight Assessment Among Hemodialysis Patients Using Body Composition Monitor. Value in Health, 20(9), A864. https://doi.org/10.1016/j.jval.2017.08.2509

42. Iftikhar, T., Rauf, M. K., Sarwar, S., Badshah, A., Waseem, D., Tahir, M. N., Khan, A., ... & Khan, G. M. (2017). Structural elucidation and bioassays of newly synthesized pentavalent antimony complexes. Journal of Organometallic Chemistry, 851, 89-96. https://doi.org/10.1016/j.jorganchem.2017.09.002

43. Dar, M. J., Ali, H., Khan, A., & Khan, G. M. (2017). Polymer-based drug delivery: the quest for local targeting of inflamed intestinal mucosa. Journal of drug targeting, 25(7), 582-596. https://doi.org/10.1080/1061186X.2017.1298601

44. Siddiqui, M. A., Khan, A., & Zaka, M. (2016). A review of structure activity relationship of amiodarone and its derivatives. Open Journal of Medicinal Chemistry, 6(02), 37. 10.4236/ojmc.2016.62003

45. Khan, A.*, Khan, A. H., Adnan, A. S., Syed Sulaiman, S. A., Gan, S. H., & Khan, I. (2016). Management of patient care in hemodialysis while focusing on cardiovascular disease events and the atypical role of hyper-and/or hypotension: a systematic review. BioMed research international, 2016. https://doi.org/10.1155/2016/9710965

46. Khan, A., Raja, M. H., Khan, A., Khan, M. W., & Khan, G. M. (2016). Synthesis and Assessment of a New Tetrahydrogeraniol Derivative as Penetration Enhancer for Transdermal Drug Delivery. Journal Of Glycomics And Metabolism, 1(1), 45-53.

47. Hussain, H., Jabeen, F., Al-Harrasi, A., Ahmad, M., Mabood, F., Hussain, J., Hassan, Z., Rehman, N., Green, I. R., Khan, A., ... & Krohn, K. (2015). Seimisochromenes A and B: two new dihydroisochromenes from the endophytic fungus, Seimatosporium sp. Journal of Asian natural products research, 17(4), 348-351. https://doi.org/10.1080/10286020.2014.972383

48. Hussain, H., Krohn, K., Al-Harrasi, A., Kouam, S. F., Abbas, G., Raees, M. A., Badshah, A., Shah, A., Zahoor, A., Khan, A.,... & Schulz, B. (2015). Microdiplanol and microdiplane: a new m-anisaldehyde and a new 24-methylcholestanol derivative from the endophytic fungus Microdiplodia sp. Journal of Asian natural products research, 17(7), 733-737. https://doi.org/10.1080/10286020.2014.989221

49. Khan A., CH, M. I., Khan, J., Khan, G. M., Hanif, M., & Khan, A. (2015). Formulation development and in vitro characterization of sustained release matrix tablets of verapamil HCl using synthetic and natural polymers. Lat. Am. J. Pharm, 34(2), 277-82.

50. Hussain, A., Khan, G. M., Khan, N. R., Khan, A., Rehman, S., Asif, H. M., ... & Yusuf, A. L. I. (2015). Transdermal Diclofenac Potassium Gels: Natural Penetration Enhancers, Can Be Effective?. Lat. Am. J. Pharm, 34(5), 1022-9.

51. Hussain, H., Root, N., Jabeen, F., Al-Harrasi, A., Al-Rawahi, A., Ahmad, M., Hassan, Z., Abbas, G., Mabood, F., Shah, A., Badshah, A., Khan, A., ... & Krohn, K. (2014). Seimatoric acid and colletonoic acid: Two new compounds from the endophytic fungi, Seimatosporium sp. and Colletotrichum sp. Chinese Chemical Letters, 25(12), 1577-1579. https://doi.org/10.1016/j.cclet.2014.06.006

52. Wahab, A., Khan, A., & Khan, G. M. (2013). Preparation and evaluation of solid dispersions of ibuprofen using glucosamine HCl as a carrier. British Journal of Pharmaceutical Research, 3(4), 722-733. http://www.sciencedomain.org/review-history.php?iid=234&id=14&aid=1551

PATENTS

1.      Khan A, Mushtaq S, Alshahrani F, Rashah KA, Mopuri R, Chinnam S, Bobbala P, Yallur BC.

Title of the invention: Smart device for the analysis of metabolic disorders

Patent number: 6303315

Status: Granted on 21 August 2023

Patent office: United Kingdom

2.      Chinnam S, Farid A, Ullah A, Badar M, Mohaini MHA, Lakkaboyana SK, Mushtaq S, Alsalman AJ, Khan A, Hawaj MAI, Almuhaini RA.

Title of the invention: Artificial Intelligence device for prediction of diabetes

Patent number: 6301395

Status: Granted on 14 August 2023

Patent office: United Kingdom

3.      Chinnam S, Farid A, Chigurupati S, Khan A, Kottam N, Zahid S, Paritala RR.

Title of the invention: Wall Mountable Autoclave

Patent number: 6287618

Status: Granted on 15 June 2023

Patent office: United Kingdom

4.      Almuhayawi MS, Alruhaili MH, Dhatwalia D, Farid A, Khan A, Sah R, Chinnam S, Selim S, Ullah I, Zahid S.

Title of the invention: A system for the synthesis and antioxidant activity of novel iminophosphoranes

Patent number: 202023102486

Status: Granted on 22 May 2023

Patent office: Germany

5.      Iqrar A, Godran AA, Chinnam S, Farid A, Khan A, Pannipara M, Patel H, Sah R.

Title of the invention: A system for the synthesis and biological evaluation of novel urea analogues

Patent number: 202023100373

Status: Granted on 09 February 2023

Patent office: Germany

CLINICAL TRIALS REGISTRATION

1.      Hafsa Kanwal and Amjad Khan

Trial Registered in ANZCTR (Australian New Zealand Clinical Trial Registry)

Registration Number: ACTRN12622000234718

Date of registration: 09-02-2022     Current status: In progress

Link: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12622000234718

2.      Hafsa Kanwal and Amjad Khan

Trial Registered in IRCT (Iranian Registry of Clinical Trials)

Registration Number: IRCT20220516054875N1

Date of registration: 23-05-2022     Current status: In progress

Link: https://www.irct.ir/trial/63607

3.      Umm-e-Kalsoom and Amjad Khan

Trial Registered in ANZCTR (Australian New Zealand Clinical Trial Registry)

Registration Number: ACTRN12622000996763

Date of registration: 15-07-2022     Current status: In progress

Link: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12622000996763

CHAPTERS AUTHORED

1.      Khan, Y.H.*, Safdar, A., Butt, M.H., Hafeez, Sara., Ahmad, Abrar., Misbah, Shahzadi., Khan, Rahima., Salman, M., Mallhi, T.H.*, Khan, T.M., Khan, A. (2023). Pancreatitis Management in Developing Countries. In: Al-Worafi, Y.M. (eds) Handbook of Medical and Health Sciences in Developing Countries. Springer, Cham. https://doi.org/10.1007/978-3-030-74786-2_25-1

2.      Khan, A., Abbas, S., Hameed, K., Mushtaq, S., Mallhi, T.H.*, Khan, Y.H., Akash, MS., Khan, G.M., Butt, M.H., Khan, T.M. (2023). Alzheimer’s Disease Management in Developing Countries. In: Al-Worafi, Y.M. (eds) Handbook of Medical and Health Sciences in Developing Countries. Springer, Cham. https://doi.org/10.1007/978-3-030-74786-2_44-1

3.      Mallhi, T.H., Kanwal, H., Kalsoom, U.E., Mushtaq, S., Akash, MSH., Khan, Y.H., Butt, M.H., Khan, T.M., Khan, A.* (2023). Thyroid Disorder Management in Developing Countries. In: Al-Worafi, Y.M. (eds) Handbook of Medical and Health Sciences in Developing Countries . Springer, Cham. https://doi.org/10.1007/978-3-030-74786-2_13-1

4.      Mallhi, T.H., Ijaz, E., Butt, M.H., Khan, Y.H.*, Shah, S., Rehman, K., Salman, M., Ullah, F., Raja, A.A., Khan, A., Khan, T.M. (2023). Benign Prostatic Hyperplasia. In: Al-Worafi, Y.M. (eds) Handbook of Medical and Health Sciences in Developing Countries. Springer, Cham. https://doi.org/10.1007/978-3-030-74786-2_87-1

5.      Khan, A.*, Abbas, S., Bibi, A., Mushtaq, S., Khan, G.M., Babar, ZUD. (2023). Interventions and Public Health Activities Performed by Community Pharmacists. In: Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. Springer, Cham. https://doi.org/10.1007/978-3-030-50247-8_140-1

6.      Mallhi, T. H., Butt, M. H., Ahmad, A., Misbah, S., Salman, M., Khan, A., Raja, A. A., & Khan, Y. H. (2022). Drug-metabolizing enzymes and fate of prodrugs: From function to regulation. Biochemistry of Drug Metabolizing Enzymes, 125-139. https://doi.org/10.1016/B978-0-323-95120-3.00005-1

7.      Khan, Y. H., Bokharee, N., Rasheed, M., Saifullah, A., Khokhar, A., Khan, S. A., Khan, A., & Mallhi, T. H. (2022). Hormones and drug-metabolizing enzymes: From function to regulation. Biochemistry of Drug Metabolizing Enzymes, 141-159. https://doi.org/10.1016/B978-0-323-95120-3.00019-1

8.      Khan, A., Khan, A., Wahid, A., Mushtaq, S., Khan, Y. H., Maqbool, F., Khan, F. U., Mallhi, T. H., & Khan, G. M. (2022). Fate of drug-metabolizing enzymes in metabolic diseases. Biochemistry of Drug Metabolizing Enzymes, 209-230. https://doi.org/10.1016/B978-0-323-95120-3.00020-8

9.      Shabbir, A., Niazi, S. G., Rehman, K., Akash, M. S. H., Kamran, S. H., & Khan, A. (2022). Fate of drug-metabolizing enzymes in cardiovascular diseases: Concepts and challenges. Biochemistry of Drug Metabolizing Enzymes, 231-258. https://doi.org/10.1016/B978-0-323-95120-3.00006-3

10. Kamran, S. H., Rehman, K., Akash, M. S. H., Khan, A., & Laher, I. (2022). Impact of physiological factors on drug-metabolizing enzymes: From function to regulation. Biochemistry of Drug Metabolizing Enzymes, 281-304. https://doi.org/10.1016/B978-0-323-95120-3.00003-8

11. Hussain H. et al. (2022) Fruitful Decade of Phoma Secondary Metabolites from 2011 to 2020: Chemistry, Chemical Diversity, and Biological Activities. In: Rai M., Zimowska B., Kövics G.J. (eds) Phoma: Diversity, Taxonomy, Bioactivities, and Nanotechnology. Springer, Cham. https://doi.org/10.1007/978-3-030-81218-8_10

12. Mallhi T.H., Khokhar A., Khan Y.H., Alotaibi N.H., Khan A. (2021) Endocrine Disrupting Chemicals Induced Childhood Obesity. In: Akash M.S.H., Rehman K., Hashmi M.Z. (eds) Endocrine Disrupting Chemicals-induced Metabolic Disorders and Treatment Strategies. Emerging Contaminants and Associated Treatment Technologies. Springer, Cham. https://doi.org/10.1007/978-3-030-45923-9_10

13. Khan A., Kanwal H., Bibi S., Mushtaq S., Khan A., Khan Y.H., Mallhi T.H. (2021) Volatile Organic Compounds and Neurological Disorders: From Exposure to Preventive Interventions. In: Akash M.S.H., Rehman K. (eds) Environmental Contaminants and Neurological Disorders. Emerging Contaminants and Associated Treatment Technologies. Springer, Cham. https://doi.org/10.1007/978-3-030-66376-6_10

14. Mallhi T.H., Saifullah A., Khan Y.H., Khan A., Alotaibi N.H., Alzarea A.I. (2021) Pathogenesis of Neurodegeneration and Associated Neurological Disorders. In: Akash M.S.H., Rehman K. (eds) Environmental Contaminants and Neurological Disorders. Emerging Contaminants and Associated Treatment Technologies. Springer, Cham. https://doi.org/10.1007/978-3-030-66376-6_1

15. Khan Y.H., Liaqat A., Mallhi T.H., Abid A., Alotaibi N.H., Khan A. (2021) Bacterial Endotoxins and Neurological Disorders: From Exposure to Therapeutic Interventions. In: Akash M.S.H., Rehman K. (eds) Environmental Contaminants and Neurological Disorders. Emerging Contaminants and Associated Treatment Technologies. Springer, Cham. https://doi.org/10.1007/978-3-030-66376-6_3

PAPERS PRESENTED

IN

INTERNATIONAL/ NATIONAL WORKSHOPS / CONFERENCES

1. Khan, A. (Invited Speaker). Knowledge, attitude and perception of Pakistani population towards COVID-19 vaccination and role of Pharmacist in dispelling vaccine myths. Oral presentation at the The 2nd International Seminar & Call For Paper (ISCP) UTA 45 Jakarta on “Promotive, Preventive, and Early Detection of Covid 19”, December 18-19, 2021, UTA 45 Jakarta, Indonesia.

2. Khan, A. (Invited Speaker). Healthcare products Use: Pharmacovigilance & Pharmacoeconomics-Evidence based selection. Oral presentation at the 11th Public Annual Public Health Conference, Sep 23-34, 2021, Health Services Academy (HSA), Islamabad, Pakistan.

3. Khan, A. (Invited Speaker). Routine pediatric vaccination in Pakistan during COVID-19: How can healthcare professionals help? Oral presentation at the 1^st International Seminar & Call For Paper (ISCP) on “Herbal Medicine for Covid-19 and How To Overcome With Pandemic Situation”, December 05-6, 2020, UTA 45 Jakarta, Indonesia.

4. Khan, A., (Invited Speaker) & Mushtaq, S. Assessment of depression among hemodialysis patients in different dialysis facilities. Oral presentation at International Scientific Drug Conference of Asia on “Research, Development and Innovations for Global Healthcare”, October 17, 2020, ST. Dominic College of Asia, Philippines.

5. Khan, A., (Invited Speaker) Khan, A.H., & Mushtaq, S. A comparative study on depression among hemodialysis patients in different dialysis facilities. Oral presentation at 20^th International Pharmacy Conference & Exhibition (IPCE) on Recent Advancements, Future Trends & Challenges in Pharmacy, 27-30^th October 2019, PC Hotel, Lahore, Pakistan.

6. Khan, A., Khan, A. H., Sulaiman, S. A., Adnan, A. S., & Mushtaq, S. Prevalence and evaluation of factors associated with depression among hemodialysis patients. [Oral presentation (Abstract code: OPP24) at 1^st JoPPP Conference on Pharmaceutical Policy and Practice Research, 28-29^th August 2019, Concorde Hotel, Shah Alam, Selangor, Malaysia.

7. Khan, A., (Invited Speaker) Khan, A.H., & Mushtaq, S. Evaluation of factors associated with late Dry-weight achievement among hemodialysis patients: Bioimpedance spectroscopy interpretation. 3rd International Conference on Recent Advancement in Pharmaceutical Research and Drug Delivery QAU Islamabad, Pakistan. Feb 19-20, 2019.

Khan, A., Khan, A. H., Sulaiman, S. A., Adnan, A. S., & Khan, I. Effect of calcium channel blockers on blood pressure in hypertensive hemodialysis patients. [Oral Presentation (Abstract code: ABS-214) at 17th Asian Conference on Clinical Pharmacy (ACCP 17), 28-30th July 2017, Yogyakarta, Indonesia].

9. Khan, A. (Invited Speaker). Healthcare products Use: Pharmacovigilance & Pharmacoeconomics-Evidence based selection. Oral presentation at the 11^th Public Annual Public Health Conference on “Contemporary Medicines, Health Technologies and Vaccines for Emerging Public Health Risks”, September 23-24^th, 2021, Health Services Academy, Islamabad, Pakistan.

10. Khan, A., Khan, A. H., Adnan, A. S., Sulaiman, S. A., & Khan, I. (2017). Dry-Weight Assessment Among Hemodialysis Patients Using Body Composition Monitor. Value in Health, 20(9), A864. (Abstract code: PMD4). Poster presented at ISPOR 6th Latin America Conference, September 15-17^th, 2017, Brazil. DOI: https://doi.org/10.1016/j.jval.2017.08.2509 (IF: 5.725).

11. Khan, I., Khan, A. H., Adnan, A. S., Aftab, R. A., & Khan, A. Effect of BMI on Serum Cystatin C among Elderly CKD type 2 Diabetic Patients (Abstract code: PP1630). Poster presented at International Conference on Pharmacy Education & Practice (ICPEP), 29-31 January 2016, Batu Feringghi Penang, Malaysia.

Khan, I., Khan, A. H., Adnan, A. S., Aftab, R. A., & Khan, A. Usefulness of Serum Cystatin C in Malaysian Elderly CKD Patients with type2 Diabetes Mellitus and Nephropathy. [Oral Presentation (Abstract code: PO1625) at International Conference on Pharmacy Education & Practice (ICPEP), 29-31 January 2016, Batu Feringghi Penang, Malaysia].

13. Khan, I., Adnan, A. S., Khan, A. H., & Khan, A. Role of Cystatin C in renal impairment among elderly CKD patients with type 2 Diabetes Mellitus (Abstract code: PP07). Poster Presented at 32nd Annual Congress of Malaysian Society of Nephrology, 29th April-1st May 2016, Persada Johor International Convention Centre, Johor Bahru, Malaysia.

Khan, A., Adnan, A. S., Khan, A. H., & Khan, I. Determination of optimal timing for blood pressure measurement in the management of Hypertensive Hemodialysis patients by using Body Composition Monitoring (BCM). (Abstract code: PP43). Poster Presented at 32nd Annual Congress of Malaysian Society of Nephrology, 29th April-1st May 2016, Persada Johor International Convention Centre, Johor Bahru, Malaysia.

CONFERENCES / SEMINARS / WORKSHOPS ORGNIZED

INTERNATIONAL:

1. Organizer of: 4th International Conference (virtual) on “Integrative multidisciplinary nanomedicine: a game changing strategy for emerging infectious diseases” sponsored by WHO Pakistan and ORIC QAU, Islamabad Pakistan on October 10, 2020.

2. Organizer of: 02-Days 3rd International Conference on "Recent Advancement in Pharmaceutical Research and Drug Delivery" sponsored by HEC, Pakistan on Feb 19-20, 2019.

CONFERENCES / SEMINARS / WORKSHOPS ATTENDED

Conference Title	Organizer	Location	Date	Sponsoring Agency
International Seminar on “Improving Stroke Care in Low and Middle Income Countries”	COMSTECH-ICCBS	COMSTECH-ICCBS	Jan 24, 2022	COMSTECH
2nd International Seminar & Call For Paper (ISCP)	UTA 45 Jakarta	UTA 45 Jakarta, Indonesia	Dec 18-19, 2021	UTA 45 Jakarta, Indonesia
11th Public Annual Public Health Conference	Health Services Academy (HSA)	HSA, Islamabad	Sep 23-34, 2021	UK aid, UNICEF etc.
The 1^st International Seminar & Call For Paper (ISCP)	UTA 45 Jakarta	UTA 45 Jakarta, Indonesia	Dec 05-6, 2020	UTA 45 Jakarta, Indonesia
International Scientific Drug Conference of Asia	ST. Dominic College of Asia	Dominic Complex, City of Bacoor, Cavite, Philippines	Oct 17, 2020	ST. Dominic College of Asia, Philippines
4th International Conference (virtual) on Integrative multidisciplinary nanomedicine: a game changing strategy for emerging infectious diseases	Department of Pharmacy, QAU	Quaid-i-Azam University, Islamabad	Oct 10, 2020	ORIC, QAU Pakistan
20th International Pharmacy Conference & Exhibition (IPCE)	Pakistan Pharmacists Association	Pearl continental Lahore	Oct 27-30, 2019	National & Multinational Pharmaceutical lndustries
1st JoPPP Conference on Pharmaceutical Policy and Practice Research	Jointly organised by UiTM and the Journal of Pharmaceutical Policy and Practice	Concorde Hotel Shah Alam, Selangor, Malaysia	August 28-29, 2019	CastleHill Global, DUOPHARMA & Pharmaniaga
3rd International Conference on Recent Advancement in Pharmaceutical Research and Drug Delivery	Department of Pharmacy, QAU	Quaid-i-Azam University, Islamabad	Feb 19-20, 2019	HEC, Pakistan
One Day “National Seminar on Intellectual Property System of Pakistan	Department of Pharmacy, QAU	Quaid-i-Azam University, Islamabad	December 21, 2018	ORIC QAU & IPO Pakistan
Developing a Systematic Review of Intervention studies for the Cochrane Collaboration School of Medical Sciences	USM Cochrane Network Site PPSP	School of Medical Sciences, Universiti Sains Malaysia	September 08-10, 2015	Cochrane network, USM
2^nd International Workshop on Pharmacy Practice/Clinical Pharmacy	HEC & Department of Pharmacy, QAU	Department of Pharmacy, Quaid-i-Azam University	Dec 15-19, 2014	HEC
Two days training workshop on Research methods in Pharmacy Practice and Clinical Pharmacy	Department of Pharmacy, Quaid-i-Azam University	Department of Pharmacy, Quaid-i-Azam University	March 11-12, 2014	Quaid-i-Azam University & International Islamic University Malaysia
One-day workshop on ‘Introduction to Pharmaceutical Policy and Practice’ delivered by the University of Auckland’s School of Pharmacy	The University of Auckland	Health services academy, Islamabad	20 December 2013	The University of Auckland
Two days symposium on Application of frontier technologies in documentation & conservation of biodiversity and climate change	Shaheed Benazir Bhutto University	Sheringal, Dir Upper	29-30 November 2013	Quaid-i-Azam University
One-day workshop on Engaging private Pharmacies in TB care & control	Dev-Net (pvt) Ltd.	Health services academy, Islamabad	22^nd September, 2013	Dev-Net (pvt) Ltd.
17th International Pharmacy Conference and Exhibition	Pakistan Pharmacists Association	Marriot Islamabad	19th- 21st April 2012	National & Multinational Pharmaceutical lndustries
16th International Pharmacy Conference and Exhibition	Pakistan Pharmacists Association	Pearl continental Lahore	28th April- 1st May, 2011	National & Multinational Pharmaceutical lndustries
3rd Two days National workshop on Quality assurance & enhancement in higher education & research	Faculty of Pharmacy, Gomal University	AQ Khan auditorium, Gomal University.	Jan 22-23, 2010	HEC & British Council Pakistan.

HONORS / AWARDS

ø Gold Medal and Merit Certificate awarded by Gomal University on achieving First-Class First-Position in Doctor of Pharmacy (Pharm.D.) Degree, Session (2007-2012).

ø Merit Scholarship throughout Pharmacy Career.

ø University of Oslo, Norway; The University of Edinburgh, UK; & Universiti Sains Malaysia (USM), Malaysia approved international supervisor for assisting/co-supervising research students.

ø Six Months Research Fellowship at UoN Chair of Oman’s Medicinal Plants and Marine Natural Products, funded by University of Nizwa, Sultanate of Oman.

ø Prime Minister’s Fee Reimbursement and Laptop Distribution Scheme for facilitating young talented graduates to improve Higher Education for the academic year 2013-14.

ø USM PhD Fellowship [Ref. no. P-FD0011/15(R)] awarded by Universiti Sains Malaysia.

ø Nominee USM Vice Chancellor Award for the year 2015.

ø Registered Pharmacist, KP Pharmacy Council, Peshawar, Pakistan.

ø Higher Education Commission (HEC) approved PhD Supervisor.

ø Current Universal Scientific Education and Research Network (USERN) Ambassador for Pakistan (https://usern.tums.ac.ir/Info/Executives).

ø Part of the Judging Panel for the 2023 QS Reimagine Education Awards (10th edition of QS Reimagine Education Awards).

HEC APPROVED PhD SUPERVISOR

In recognition of my teaching/research achievements, the Higher Education Commission (HEC) of Pakistan has awarded me the status of ‘Accredited PhD Supervisor’ to supervise M-Phil & PhD level research projects.

PhD & M.Phil. RESEARCH THESIS SUPERVISED

PhD Thesis Presently under Supervision: 05

M.Phil. Thesis Supervised: 09

M.Phil. Thesis Presently under Supervision: 10

International students’ Co-supervision

M.Phil. Thesis Co-supervised: 01

PhD Thesis presently under Co-supervision: 02

INTERNATIONAL LINKAGES DEVELOPED/ ESTABLISHED

1. “Establishment of Sino-Pak Pharmacoeconomics and Outcomes Research Network”. Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmacy, Xi’an Jiaotong University (Link Coordinator: Dr. Amjad Khan & Prof. Dr. Yu Fang)

2. School of Pharmacy, Universitas 17 Agustus 1945 Jakarta, Indonesia (Link Coordinator: Dr. Amjad Khan & Dr. Diana Laila Ramatillah)

3. Division of Pharmacy Practice and Policy, School of Pharmacy, University of Nottingham, University Park, Nottingham, NG7 2RD, United Kingdom (Link Coordinator: Dr. Amjad Khan & Dr. Matthew Boyd)

4. Department of Community Medicine and Global Health, University of Oslo, Norway (Link Coordinator: Dr. Amjad Khan & Dr. Muhammad Asaduzzaman)

5. Usher Institute for Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK (Link Coordinator: Dr. Amjad Khan & Prof. David Weller)

6. Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, USM, Malaysia (Link Coordinator: Dr. Amjad Khan & Dr. Amer Hayat Khan)

1. RESEARCH PROJECTS PRESENTLY UNDER INVESTIGATION

S/No

Project Title

Principal / Co-Principal Investigator

Amount (Rs.)

Sponsoring Agency

Duration

1

Evaluation and Management of COPD and other Comorbidities in COPD Patients by Dispensing Pharmaceutical Care

following the GOLD guidelines 2020: A Prospective Clinical Trial

Principal Investigator

1.373

Millions

Higher Education Commission, Pakistan.

2 years

(In Progress)

From: April 2022 to April 2024

NATIONAL & INTERNATIONAL RESEARCH PROJECTS SUBMITTED FOR APPROVAL

1. “Pharmacist-led interventions in management of anemia among dialysis patients: a randomized controlled trial”.

Funding Agency: Pakistan Council for Science and Technology (PCST)

2. “Stenting in Coronary Artery Disease Patients: A comparison of Clinical and Economic Outcomes of 2nd and 3rd Generation Drug Eluting Stents”.

Funding Agency: Pakistan Council for Science and Technology (PCST)

3. “Evaluation of COVID-19 burden of disease and sero-epidemiological surveys among specific populations”. Funding Agency: Pfizer Covid-19 vaccine grants

4. “Measuring the impact of efforts to overcome vaccine hesitancy and enhance vaccine uptake”. Funding Agency: Pfizer Covid-19 vaccine grants

“Pharmacist-led Intervention for Disease Management and Risk Reduction in Patients with Ischemic Heart Disease”. Funding Agency: Higher Education Commission (HEC), Pakistan.